[1]SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA:A Cancer Journal for Clinicians,2021,71(3):209-249.
[2]KARIMI P,ISLAMI F,ANANDASABAPATHY S,et al.Gastric cancer:Descriptive epidemiology,risk factors,screening,and prevention[J].Cancer Epidemiol Biomarkers & Prevention,2014,23(5):700-713.
[3]SMYTH EC,LAGERGREN J,FITZGERALD RC,et al.Oesophageal cancer[J].Nature Reviews Disease Primers,2017,3(1):1-21.
[4]WANG D,DAI J,SUO C,et al.Molecular subtyping of esophageal squamous cell carcinoma by large-scale transcriptional profiling:Characterization,therapeutic targets,and prognostic value[J].Frontiers in Genetics,2022,13(1):1033214.
[5]SUNG H,HU N,YANG HH,et al.Association of high-evidence gastric cancer susceptibility loci and somatic gene expression levels with survival[J].Carcinogenesis,2017,38(11):1119-1128.
[6]CHEVALLAY M,BOLLSCHWEILER E,CHANDRAMOHAN SM,et al.Cancer of the gastroesophageal junction:A diagnosis,classification,and management review[J].Annals of the New York Academy of Sciences,2018,1434(1):132-138.
[7]HUI Z,XIANGLIN M.Association of HOTAIR expression with PI3K/Akt pathway activation in adenocarcinoma of esophagogastric junction[J].Open Medicine,2016,11(1):36-40.
[8]ALSINA M,DIEZ M,TABERNERO J.Emerging biological drugs for the treatment of gastroesophageal adenocarcinoma[J].Expert Opinion on Emerging Drugs,2021,26(4):385-400.
[9]HENDRY S,SALGADO R,GEVAERT T,et al.Assessing tumor infiltrating lymphocytes in solid tumors:A practical review for pathologists and proposal for a standardized method from the International Immuno-oncology Biomarkers Working Group:Part 1:Assessing the host immune response,TILs in invasive breast carcinoma and ductal carcinoma in situ,metastatic tumor deposits and areas for further research[J].Advances in Anatomic Pathology,2017,24(5):235-251.
[10]EISMANN L,RODLER S,BUCHNER A,et al.Identification of the tumor infiltrating lymphocytes(TILs) landscape in pure squamous cell carcinoma of the bladder[J].Cancers,2022,14(16):3999.
[11]HENDRY S,SALGADO R,GEVAERT T,et al.Assessing tumor infiltrating lymphocytes in solid tumors:A practical review for pathologists and proposal for a standardized method from the International Immuno-oncology Biomarkers Working Group:Part 2:TILs in melanoma,gastrointestinal tract carcinomas,non-small cell lung carcinoma and mesothelioma,endometrial and ovarian carcinomas,squamous cell carcinoma of the head and neck,genitourinary carcinomas,and primary brain tumors[J].Advances in Anatomic Pathology,2017,24(6):311-335.
[12]RAKAEE M,ADIB E,RICCIUTI B,et al.Association of machine learning-based assessment of tumor-infiltrating lymphocytes on standard histologic images with outcomes of immunotherapy in patients with NSCLC[J].JAMA Oncology,2023,9(1):51-60.
[13]YOO SY,PARK HE,KIM JH,et al.Whole-slide image analysis reveals quantitative landscape of tumor-immune microenvironment in colorectal cancers[J].Clinical Cancer Research,2020,26(4):870-881.
[14]BAI Y,COLE K,MARTINEZ-MORILLA S,et al.An open-source,automated tumor-infiltrating lymphocyte algorithm for prognosis in triple-negative breast cancer[J].Clinical Cancer Research,2021,27(20):5557-5565.
[15]KOS Z,ROBLIN E,KIM RS,et al.Pitfalls in assessing stromal tumor infiltrating lymphocytes(sTILs) in breast cancer[J].NPJ Breast Cancer,2020,6(1):17.
[16]GAO P,CAI N,YANG X,et al.Association of Helicobacter pylori and gastric atrophy with adenocarcinoma of the esophagogastric junction in Taixing,China[J].International Journal of Cancer,2022,150(2):243-252.
[17]YANG X,CHEN X,ZHUANG M,et al.Smoking and alcohol drinking in relation to the risk of esophageal squamous cell carcinoma:A population-based case-control study in China[J].Scientific Reports,2017,7(1):17249.
[18]ZHANG T,YANG X,YIN X,et al.Poor oral hygiene behavior is associated with an increased risk of gastric cancer:A population-based case-control study in China[J].Journal of Periodontology,2022,93(7):988-1002.
[19]YUAN Y,FAILMEZGER H,RUEDA OM,et al.Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling[J].Science Translational Medicine,2012,4(157):162-171.
[20]DIECI MV,RADOSEVIC-ROBIN N,FINEBERG S,et al.Update on tumor-infiltrating lymphocytes(TILs) in breast cancer,including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ:A report of the International Immuno-oncology Biomarker Working Group on breast cancer[J].Seminars in Cancer Biology,2018,52(1):16-25.
[21]SALGADO R,DENKERT C,DEMARIA S,et al.The evaluation of tumor-infiltrating lymphocytes(TILs) in breast cancer:Recommendations by an International TILs Working Group 2014[J].Annals of Oncology,2015,26(2):259-271.
[22]BECK AH,SANGOI AR,LEUNG S,et al.Systematic analysis of breast cancer morphology uncovers stromal features associated with survival[J].Science Translational Medicine,2011,3(108):108-113.
[23]KLAUSCHEN F,MLLER KR,BINDER A,et al.Scoring of tumor-infiltrating lymphocytes:From visual estimation to machine learning[J].Seminars in Cancer Biology,2018,52(1):151-157.
[24]UGOLINI F,DE LOGU F,IANNONE LF,et al.Tumor-infiltrating lymphocyte recognition in primary melanoma by deep learning convolutional neural network[J].The American Journal of Pathology,2023,193(12):2099-2110.
[25]SUN P,HE J,CHAO X,et al.A computational tumor-infiltrating lymphocyte assessment method comparable with visual reporting guidelines for triple-negative breast cancer[J].EBio Medicine,2021,70(1):103492.